News

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

February 26, 2026 signalgroup

New Report by IQVIA Institute for Human Data Science Outlines ASP Policies to Support Prescription Drug Affordability and Lower-Cost Biosimilars

February 6, 2026 signalgroup

The Biosimilars Forum Applauds the FTC for Requiring PBMs to Increase Transparency and Lower Prescription Drug Prices

February 4, 2026 signalgroup

The Biosimilars Forum Applauds the Trump Administration and Members of Congress for Lowering Prescription Drug Prices through PBM Reform

December 10, 2025 signalgroup

Biosimilars Forum Calls for Congress to Pass the Skinny Labels, Big Savings Act to Support Safe, Effective and Lower-Cost Biosimilars

October 29, 2025 signalgroup

Biosimilars Forum Applauds FDA Commissioner Dr. Marty Makary for Supporting Safe, Effective and Lower-Cost Biosimilars

October 29, 2025 signalgroup

The Biosimilars Forum Thanks and Commends Trump Administration Healthcare Leaders for Supporting Lower-Cost, Safe and Effective Biosimilars

October 7, 2025 signalgroup

The Biosimilars Forum Calls for State Policies that Support Lower-Cost Prescription Drugs Including Biosimilars for Patients that Need Them

September 22, 2025 Katie Quinn

The Biosimilars Forum Applauds Representative Pfluger (R – TX) and Representative Landsman (D – OH) for Helping Make Lower-Cost Medicines Available to Americans

May 22, 2025 signalgroup

Biosimilars Forum Submits Comments to Accelerate Safe and Effective Biosimilar Development by Modernizing the FDA and Eliminating Bureaucratic Inefficiencies

May 13, 2025 signalgroup

Biosimilars Forum Applauds House of Representatives Committee on Energy and Commerce for Including PBM Reform in Reconciliation Package